[Clinical study of a new hypoglycemic sulfamide: glibenclamide or HB 419].
D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013449:Sulfonamides / Q000627:therapeutic use*; D013997:Time Factors
D007004:Hypoglycemic Agents; D013449:Sulfonamides
Etude clinique d'un nouveau sulfamide hypoglycémiant: le glibenclamide ou HB 419.